{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:13:50Z","timestamp":1790745230890,"version":"4.1.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T00:00:00Z","timestamp":1419552000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0116166","type":"journal-article","created":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T19:35:00Z","timestamp":1419622500000},"page":"e116166","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Novel Model of IgE-Mediated Passive Pulmonary Anaphylaxis in Rats"],"prefix":"10.1371","volume":"9","author":[{"given":"Eva","family":"Wex","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,12,26]]},"reference":[{"key":"ref1","unstructured":"World Health Organization<bold>.<\/bold> Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs307\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs307\/en\/<\/ext-link>. Accessed 2014 November 25."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S502","DOI":"10.1067\/mai.2003.94","article-title":"6. Asthma","volume":"111","author":"RF Lemanske Jr","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"ref3","unstructured":"Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2012<bold>.<\/bold> Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ginasthma.org\/\" xlink:type=\"simple\">http:\/\/www.ginasthma.org\/<\/ext-link>. Accessed 2014 November 25."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"32899","DOI":"10.1074\/jbc.R110.206466","article-title":"Biochemical basis of asthma therapy","volume":"286","author":"PJ Barnes","year":"2011","journal-title":"J Biol Chem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa012705","article-title":"Mast-cell infiltration of airway smooth muscle in asthma","volume":"346","author":"CE Brightling","year":"2002","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1440-1711.2001.00983.x","article-title":"Regulation of the inflammatory response in asthma by mast cell products","volume":"79","author":"PH Hart","year":"2001","journal-title":"Immunol Cell Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1465-9921-11-107","article-title":"The early asthmatic response is associated with glycolysis, calcium binding and mitochondria activity as revealed by proteomic analysis in rats","volume":"11","author":"YD Xu","year":"2010","journal-title":"Respir Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4168\/aair.2009.1.1.3","article-title":"Allergen-induced airway inflammation and its therapeutic intervention","volume":"1","author":"PM O'Byrne","year":"2009","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Castells MC (2011) Anaphylaxis and Hypersensitivity Reactions. ed. Humana Press, Springer Science+Business Media, LLC New York.","DOI":"10.1007\/978-1-60327-951-2"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4049\/jimmunol.81.4.355","article-title":"Passive cutaneous anaphylaxis in the mouse","volume":"81","author":"Z Ovary","year":"1958","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1242\/dmm.000323","article-title":"Mouse models of allergic asthma: acute and chronic allergen challenge","volume":"1","author":"AT Nials","year":"2008","journal-title":"Dis Model Mech"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jaci.2011.01.022","article-title":"Mast cell-associated alveolar inflammation in patients with atopic uncontrolled asthma","volume":"127","author":"CK Andersson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI114051","article-title":"Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis","volume":"83","author":"LB Schwartz","year":"1989","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1517\/13543770903207039","article-title":"Therapeutic prospect of Syk inhibitors","volume":"19","author":"P Ruzza","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/14728222.9.5.901","article-title":"Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis","volume":"9","author":"M Ulanova","year":"2005","journal-title":"Expert Opin Ther Targets"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: a crucial player in diverse biological functions","volume":"10","author":"A Mocsai","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1165\/rcmb.2005-0298OC","article-title":"Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation","volume":"34","author":"S Matsubara","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.200503-361OC","article-title":"Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness","volume":"173","author":"S Matsubara","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1002\/eji.201141502","article-title":"Induced Syk deletion leads to suppressed allergic responses but has no effect on neutrophil or monocyte migration in vivo","volume":"41","author":"E Wex","year":"2011","journal-title":"Eur J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0019-5154.110832","article-title":"Pharmacology of antihistamines","volume":"58","author":"MK Church","year":"2013","journal-title":"Indian J Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1517\/14740338.2013.788148","article-title":"Safety evaluation of desloratadine in allergic rhinitis","volume":"12","author":"V Gonzalez-Nunez","year":"2013","journal-title":"Expert Opin Drug Saf"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2222.1997.tb00745.x","article-title":"Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells","volume":"27","author":"A Genovese","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Barnes PJ (1991) Histamine receptors in the lung. Agents Actions Suppl 33 103\u2013122.","DOI":"10.1007\/978-3-0348-7309-3_9"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2125.1979.tb00927.x","article-title":"Effects of H1- and H2-receptor blocking agents on histamine-induced bronchoconstriction in non-asthmatic subjects","volume":"7","author":"JG Maconochie","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/10600280870211P102","article-title":"Cromolyn sodium: a review of mechanisms and clinical use in asthma","volume":"21","author":"S Murphy","year":"1987","journal-title":"Drug Intell Clin Pharm"},{"key":"ref26","first-page":"537","article-title":"Inhibition of immediate hypersensitivity reactions by disodium cromoglycate","volume":"13","author":"DS Thomson","year":"1973","journal-title":"Clin Exp Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0306-3623(98)00080-9","article-title":"Regulation of human mast cell and basophil function by cAMP","volume":"31","author":"MC Weston","year":"1998","journal-title":"Gen Pharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0116166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T04:38:20Z","timestamp":1690778300000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0116166"}},"subtitle":[],"editor":[{"given":"Bernhard","family":"Ryffel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,26]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0116166","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,26]]}}}